Nrf2酸化有助于通过PKCδ通路获得细胞周围细胞重编程
Rika Sakuma1, Yusuke Minato1, Seishi Maeda1
1Department of Anatomy and Cell Biology, Faculty of Medicine, Hyogo Medical University, 1-1, Mukogawa-cho, Nishinomiya-shi, Hyogo 663-8501, Japan.
Neurobiology of disease
|February 3, 2025
概括
通过PKCδ的核因子红色素-2相关因子2 (Nrf2) 酸化对于在中风后将正常的细胞周细胞 (PCs) 转化为干细胞类细胞至关重要. 抑制PKCδ可能为缺血性损伤提供一种新的治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 血管生物学 血管生物学
背景情况:
- 细胞 (PCs) 是微容器中的壁画细胞.
- 脑卒中可以诱导PC重编程成类似干细胞的细胞.
- 核因子红色素-2-相关因子2 (Nrf2) 保护免受缺血性氧化应激,并促进PC重编程.
研究的目的:
- 为了研究驱动Nrf2诱导中风的分子机制.
- 探索蛋白激酶C三角酶 (PKCδ) 在Nrf2激活和PC重编程中的作用.
主要方法:
- 使用C.B-17鼠标模型的中风.
- 检查了氧化应激标志物和酸化Nrf2 (pNrf2) 表达.
- 在体外注射了PKCδ抑制剂,并在缺血性PC (iPCs) 中评估了干细胞标志物表达.
主要成果:
- 在脑膜细胞和反应性PC中,中风诱导的氧化应激和pNrf2先于内斯表达.
- 抑制PKCδ抑制了pNrf2的激活,并恢复了iPCs中的干细胞标志物表达.
- 抑制PKCδ可以降低iPCs的产生.
结论:
- 通过PKCδ介导的Nrf2酸化是中风后PC重编程的一个关键事件.
- 通过PKCδ抑制向Nrf2酸化,为缺血性中风治疗提供了一个潜在的治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Protein Kinases and Phosphatases
13.0K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.0K
Receptor Tyrosine Kinases
12.2K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.2K


